查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球乳房切片市场：市场规模、占有率、成长分析、类型、应用 - 产业预测，2023-2030 年
市场调查报告书
商品编码
1396196

全球乳房切片市场：市场规模、占有率、成长分析、类型、应用 - 产业预测，2023-2030 年

Global Breast Biopsy Market Size, Share, Growth Analysis, By Type(Vacuum assisted biopsy, core needle biopsy and fine needle aspiration biopsy), By Application(Hospitals and clinics, diagnostic centres) - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计2021年全球乳房切片市场规模为7.9亿美元，从2022年的8.5亿美元成长到2030年的8.5亿美元，预测期间（2023-2030年）复合年增长率为8.4%，预计将成长至16.3亿美元。

全球乳房切片市场涵盖各种旨在评估乳房组织是否有潜在异常和乳癌迹象的诊断程序，是医疗保健行业中一个充满活力且快速扩张的市场。这就是我所工作的领域。推动这一市场的关键因素包括全球乳癌发病率上升、对早期检测和诊断的日益重视、诊断成像方式和切片检查技术的进步以及对微创手术的日益偏好。市场提供多种切片检查方法，包括粗针穿刺切片、真空辅助切片检查、细针抽吸和手术切片检查。一个显着的趋势是越来越多地采用影像引导切片检查，例如超音波引导切片检查、乳房 X 光检查引导切片检查和磁振造影(MRI) 引导切片检查，这提高了准确性，而且准确性正在不断提高。此外，自动切片检查枪、手持式切片检查设备和立体定位切片检查系统等创新切片检查设备和系统的出现提高了手术效率和患者舒适度。儘管北美目前由于乳癌发病率高、医疗基础设施发达以及有利的报销政策而在全球市场占据主导地位，但亚太和拉丁美洲的新兴国家预计将显着增长。促成这一增长的因素包括医疗保健支出的增加、医疗设施的改善以及对乳癌筛检意识的提高。总之，随着医疗保健系统优先考虑乳癌的早期检测和准确诊断，全球乳房切片市场预计将显着扩大，最终改善患者的治疗结果并降低死亡率。

自上而下和自下而上的方法已用于估计和检验全球乳房切片市场的规模，并估计其他各个相关子市场的规模。用于估计市场规模的调查方法包括以下细节：确定市场主要企业的二次研究以及确定各自区域的市场占有率的主要和二次研究。整个过程包括研究主要企业的年度和财务报告以及广泛的采访，以获得执行长、副总裁、董事和行销负责人等行业领导者的重要见解。所有占有率比率和细目分类均使用二手资讯确定并使用主要资讯检验。本研究涵盖的所有可能影响市场的参数都经过了详细的考虑和研究，透过初步研究检验和分析，以获得最终的定量和定性资料。

乳房切片全球市场細項分析

全球乳房切片市场按类型、应用和地区细分。按类型划分，市场分为真空辅助切片检查、粗针穿刺切片和细针抽吸切片检查。根据应用，市场分为医院/诊所和诊断中心。从区域来看，市场分为北美、欧洲、亚太地区、中东和非洲以及拉丁美洲。

全球乳房切片市场的驱动因素

乳癌发生率增加：

全球乳房切片市场的主要驱动因素是全球乳癌发生率的上升。作为全球最常见的癌症之一，乳癌的发生率持续上升。乳癌病例数的这些趋势凸显了早期检测、诊断和治疗的日益重要性，并推动了对乳房切片的需求。准确可靠的诊断技术对于识别乳房异常并促进及时干预的必要性极大地促进了乳房切片市场的成长。

全球乳房切片市场的抑制因素

假阴性或假阳性的可能性：

全球乳房切片市场的一个重要抑制因素是假阴性和假阳性的可能性。乳房切片在诊断乳癌中发挥至关重要的作用，但存在错误结果的固有风险。当切片检查中未检测到癌细胞时，就会出现假阴性结果，导致延迟或漏诊。相反，假阳性结果可能会给患者带来不必要的焦虑、额外的检测和侵入性操作。这些诊断准确性的限制损害了乳房切片程序的可靠性，并为医疗保健专业人员和患者做出资讯的治疗决策带来了挑战。

全球乳房切片市场趋势

全球乳房切片市场的主要趋势是越来越多地采用影像引导切片检查技术。超音波引导切片检查、乳房X光检查引导切片检查和磁振造影（MRI）引导切片检查等技术越来越受欢迎。这些方法利用先进的显像模式来精确定位和收集可疑的乳房病变，与传统切片检查方法相比，提高了准确性并减少了侵入性。即时影像导引有助于目标部位的可视化，从而提高诊断率并最大限度地减少重复手术的需要。影像导引切片检查的日益普及反映了该行业致力于提高乳房切片手术的准确性和效率，同时优先考虑患者舒适度并降低手术风险。Masu。

目录

  • 执行摘要
  • 调查方法
  • 母市场分析
  • 主要市场考察
    • 技术分析
    • 价格分析
    • 供应链分析
    • 价值链分析
    • 市场生态系统
    • 智慧财产权分析
    • 贸易分析
    • Start-Ups分析
    • 原料分析
    • 创新矩阵
    • 研发线产品分析
    • 总体经济指标
    • 主要投资分析
    • 关键成功因素
    • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
    • 监管形势
    • 波特的分析
    • 对未来中断的特殊考察
  • 全球乳房切片市场：按类型
    • 市场概况
    • 真空辅助切片检查
    • 空心针切片和细针抽吸切片检查
  • 全球乳房切片市场：按应用分类
    • 市场概况
    • 医院和诊所
    • 诊断中心
  • 全球乳房切片市场规模：按地区
    • 市场概况
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 西班牙
      • 法国
      • 英国
      • 其他欧洲国家地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地区
    • 中东和非洲 (MEA)
      • 海湾合作委员会国家
      • 南非
      • 其他中东/非洲地区
  • 竞争形势
    • 前5名企业对比
    • 主要企业市场定位（2021年）
    • 主要市场参与者所采取的策略
    • 关键成功策略
    • 近期市集活动
    • 主要企业市场占有率（2021年）
  • 主要企业简介
    • Ethicon Endo Surgery
    • CR Bard, Inc.
    • Becton and Dickinson Company
    • Leica Biosystems Nussloch GmbH
    • Encapsule Medical Devices LLC.
    • Hologic Inc.
    • Intact Medical Corporation
    • Galini SRL
    • Argon Medical Devices
    • Cook Medical Incorporated
    • Medtronic plc
    • Devicor Medical Products, Inc.
    • Carestream Health, Inc.
    • Planmed Oy
    • NIPRO Medical Corporation
    • Seno Medical Instruments, Inc.
    • Scion Medical Technologies LLC
    • Biopsybell Srl
    • STERYLAB Srl
    • Medicon Hellas SA
简介目录
Product Code: SQMIG35A2467

Global Breast Biopsy Market size was valued at USD 0.79 billion in 2021 and is poised to grow from USD 0.85 billion in 2022 to USD 1.63 billion by 2030, at a CAGR of 8.4% during the forecast period (2023-2030).

The global breast biopsy market stands as a dynamic and rapidly expanding sector within the healthcare industry, encompassing various diagnostic procedures aimed at assessing breast tissue for potential abnormalities or signs of breast cancer. Key drivers propelling this market include the escalating worldwide incidence of breast cancer, a growing emphasis on early detection and diagnosis, advancements in imaging modalities and biopsy techniques, and an increasing preference for minimally invasive procedures. The market offers a diverse array of biopsy methods, including core needle biopsy, vacuum-assisted biopsy, fine needle aspiration, and surgical biopsy. A notable trend is the rising adoption of image-guided biopsy procedures such as ultrasound-guided, mammography-guided, and magnetic resonance imaging (MRI)-guided biopsies, providing heightened accuracy and precision. Additionally, the market is witnessing the emergence of innovative biopsy devices and systems, including automated biopsy guns, handheld biopsy devices, and stereotactic biopsy systems, enhancing procedural efficiency and patient comfort. While North America currently dominates the global market due to high breast cancer prevalence, well-established healthcare infrastructure, and favorable reimbursement policies, emerging economies in Asia-Pacific and Latin America are anticipated to experience significant growth. Factors contributing to this growth include increasing healthcare expenditure, improved healthcare facilities, and rising awareness about breast cancer screening. In summary, the global breast biopsy market is poised for substantial expansion as healthcare systems prioritize early detection and precise diagnosis of breast cancer, ultimately leading to improved patient outcomes and reduced mortality rates.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Biopsy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Biopsy Market Segmental Analysis

The Global Breast Biopsy Market is segmented by type, application, and region. Based on type, the market can be segmented into Vacuum assisted biopsy, core needle biopsy and fine needle aspiration biopsy. Based on application, the market is segmented into Hospitals and clinics, diagnostic centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Breast Biopsy Market

Increasing Incidence of Breast Cancer:

A key driver for the Global Breast Biopsy Market is the escalating worldwide incidence of breast cancer. As one of the most prevalent cancers globally, the frequency of breast cancer has been consistently on the rise. This upward trend in breast cancer cases underscores the increasing importance of early detection, diagnosis, and treatment, thereby boosting the demand for breast biopsy procedures. The imperative for accurate and reliable diagnostic techniques to identify breast abnormalities and facilitate timely intervention has significantly contributed to the growth of the breast biopsy market.

Restraints in the Global Breast Biopsy Market

Potential for False-Negative or False-Positive Results:

A notable restraint for the Global Breast Biopsy Market is the potential for false-negative or false-positive results. While breast biopsies play a pivotal role in diagnosing breast cancer, the inherent risk of erroneous outcomes exists. False-negative results may occur when the biopsy fails to detect cancerous cells, leading to delayed or missed diagnoses. Conversely, false-positive results can induce unnecessary anxiety, additional testing, and potentially invasive procedures for patients. These limitations in diagnostic accuracy can undermine confidence in the reliability of breast biopsy procedures, posing challenges to healthcare providers and patients in making informed treatment decisions.

Market Trends of the Global Breast Biopsy Market

A key trend in the global breast biopsy market is the increasing adoption of image-guided biopsy techniques. Techniques such as ultrasound-guided, mammography-guided, and magnetic resonance imaging (MRI)-guided biopsies have gained significant popularity. These methods leverage advanced imaging modalities to precisely target and sample suspicious breast lesions, offering improved accuracy and reduced invasiveness compared to traditional biopsy methods. Real-time imaging guidance enhances visualization of the target area, resulting in better diagnostic yield and minimizing the need for repeated procedures. The growing adoption of image-guided biopsies reflects the industry's commitment to enhancing the accuracy and efficiency of breast biopsy procedures while prioritizing patient comfort and reducing procedural risks.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Breast Biopsy Market by Type
    • Market Overview
    • Vacuum assisted biopsy
    • core needle biopsy and fine needle aspiration biopsy
  • Global Breast Biopsy Market by Application
    • Market Overview
    • Hospitals and clinics
    • diagnostic centres
  • Global Breast Biopsy Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Ethicon Endo Surgery (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • C. R. Bard, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Becton and Dickinson Company (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Leica Biosystems Nussloch GmbH (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Encapsule Medical Devices LLC. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Hologic Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Intact Medical Corporation (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Galini SRL (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Argon Medical Devices (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Cook Medical Incorporated (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Medtronic plc (Ireland)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Devicor Medical Products, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Carestream Health, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Planmed Oy (Finland)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • NIPRO Medical Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Seno Medical Instruments, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Scion Medical Technologies LLC (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Biopsybell S.r.l. (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • STERYLAB S.r.l. (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Medicon Hellas S.A. (Greece)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments